Imelda Mayor

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Simeng Lin, Nicholas A. Kennedy, Aamir Saifuddin et al. · Nature Communications · 2022 · 81 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

The Role of Blood Pressure in Lacunar Strokes Preceded by TIAs

Patrice H. Lalive, Imelda Mayor, Roman Sztajzel · Cerebrovascular Diseases · 2003 · 37 citations

Medicine, Neurology, Pharmacotherapy +17

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Zhigang Liu, Kaixing Le, Xin Zhou et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 35 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Microembolic signals and carotid plaque morphology: a study of 71 patients with moderate or high grade carotid stenosis

Imelda Mayor, Mario Comelli, Evguenia Vassileva et al. · Acta Neurologica Scandinavica · 2003 · 30 citations

Medicine, Neurology, Cerebrovascular Surgery +15

[When and how do we treat our hypercholesterolemic patients?].

Sergi Bonet, Isabelle Villena, P Tomás Santos et al. · PubMed · 1999 · 13 citations

Pharmacy, Cardiology, Pharmacotherapy +12